期刊文献+

内蒙古牧区乳酸杆菌的分离及其药敏性检测

Isolation and antibiotic susceptibility of Lactic acid bacteria from pastoral areas in Inner Mongolia
下载PDF
导出
摘要 以内蒙古牧区自然发酵的乳及乳制品中分离的18株乳酸杆菌为研究对象,首先通过菌株形态学和生理生化鉴定,然后采用二倍稀释法,测定了目前临床常用的3种氟喹诺酮类药物(左氧氟沙星、诺氟沙星和环丙沙星)对这18株乳酸杆菌的药物最低抑菌浓度(MIC),结果表明,这18株试验菌株均属于乳酸杆菌属,且这18株乳酸杆菌中有16株乳酸杆菌对这3种氟喹诺酮类药物均表现为不同程度的耐药,耐药率高达82.8%,有1株表现为敏感,1株对三种氟喹诺酮类药物分别表现为敏感、耐药和中介。 The test is based on 18 strains of Lactic acid bacteria separated from milk and dairy products in pastoral areas Inner Mongolia. Firstly, their characteristics of morphological physiological and biochemical were studied. And then used the double dilution method to determinate the bacteria's' minimum bacteriostasis concentration (MIC) on three kinds of Fluoroquinolone drugs (Levofloxacin,Norfloxacin and Ciprofloxacin) which are widely used in current clinical . The results indicate that all of 18 tested strains belong to the Lactobacillus. Among the 18 strains Lactic add bacteria there are 16 strains show different degrees of drug resistance to the 3 kinds of Fluoroquinolone .And the highest rate is 82.8%.As for the other strains, one of them perform sensitive, the other one respectively perform sensitive, resistance and intermediary of the 3 species Fhioroquinolone drugs.
出处 《中国乳品工业》 CAS 北大核心 2014年第3期30-32,35,共4页 China Dairy Industry
基金 内蒙古高等学校科学研究项目(NJ09059) 国家自然科学基金项目(31060014)
关键词 乳酸杆菌 氟喹诺酮类药物 MIC Lactic acid bacteria Fluoroquinolone drugs MIC
  • 相关文献

参考文献8

  • 1刘小杰,何国庆,袁长贵.益生菌的安全性及其功能[J].中国乳品工业,2002,30(1):16-18. 被引量:23
  • 2BORRIELLO S P. Safety of Probiotics that Contain LactobaciUi or Bifidobacteria[J]. Clin Infect Dis,2003,15:775-780.
  • 3MATHUR S, SINGH R.Antibiotic Resistance in Food Lactic Acid Bacteria Review[J].Int. J. Food Microbiol,2005, 105(3): 281-295.
  • 4赵胜娟,赵暄,罗红霞,任发政.新疆传统乳制品中乳酸菌的分离鉴定[J].中国乳品工业,2007,35(11):8-11. 被引量:12
  • 5内村泰,岗田早苗.乳酸菌试验手册(日文版)[M].日本束京都新宿区新小川町6-29,朝仓书店.1992.
  • 6DANIELSON M, WIND A. Susceptibility of LactobaciUus spp. to An- timicrobial Agents [J]. International Journal of Food Microbiology, 2003,82: 1-11.
  • 7CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. CLSI document M100- S23[S]. Wayne, PA: Clinical and Laboratory Standards Institute,2013.
  • 8胡兴戎.细菌DNA促旋酶和拓扑异构酶IV基因突变与其喹诺酮耐药性的相关性[J].国外医药(抗生素分册),1999,20(3):126-128. 被引量:11

二级参考文献12

共引文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部